Panmure Gordon successfully placed a total of 41,005,500 new ordinary shares at a price of 28 pence per share to raise approximately £11.5 million (before expenses) for Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines.

The New Shares being issued represent approximately 7.5 per cent. of the issued ordinary share capital of the Company prior to the Placing. The Placing Price represents a discount of 0.6 per cent to the average mid-market closing price over the previous 60 trading days up to and including 16 November 2015, being the last practicable day before the announcement of the Placing.